Shareholders Meeting. Same old same old. Was anybody there? 2 guys accepted every motion and seconded them but not one question asked about financing, companies health, dates always being pushed back etc. For me this was a re-hash of last years meeting with some new slides and the dates pushed back and everything they wanted approved. Scientific side of company sounds promising but all else, not so much. Anyone else listen and have any feedback? Biggest disappointment was not one question asked.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.